Literature DB >> 20132044

Antitumor activities and immunomodulatory effects of ginseng neutral polysaccharides in combination with 5-fluorouracil.

Weihua Ni1, Xu Zhang, Bo Wang, Yan Chen, Han Han, Yuying Fan, Yifa Zhou, Guihua Tai.   

Abstract

A neutral polysaccharide fraction (WGPN) prepared from Panax ginseng C.A. Meyer by hot water extraction and DEAE-cellulose chromatography was tested for its anticancer activity alone and in combination with 5-fluorouracil (5-FU) in Sarcoma-180 (S180) tumor-bearing mice by intragastric administration. WGPN alone inhibited S180 tumor growth in a bell-shaped dose-response curve, and the combination with 5-FU showed a synergistic effect. Studies of various immunological activities in S180-bearing mice revealed that WGPN stimulated the proliferation of lymphocytes, increased natural killer cell cytotoxicity, enhanced the phagocytosis and nitric oxide production by macrophages, and increased the level of tumor necrosis factor-alpha in serum. In combination with 5-FU, WGPN mitigated damage to the immune system caused by 5-FU in S180-bearing mice. These results suggest that WGPN might be a potential adjuvant for chemotherapeutic drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20132044     DOI: 10.1089/jmf.2009.1119

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  24 in total

1.  Phenotypic and functional analysis of the modification of murine bone marrow dendritic cells (BMDCs) induced by neutral Ginseng polysaccharides (NGP).

Authors:  Jingjuan Meng; Yiming Meng; Zaifu Liang; Lin Du; Zhenjie Zhang; Xu Hu; Fengping Shan
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

2.  Adjuvant effects of fermented red ginseng extract on advanced non-small cell lung cancer patients treated with chemotherapy.

Authors:  Shu-Long Jiang; Hong-Jie Liu; Zhao-Chun Liu; Ning Liu; Rui Liu; Young-Reep Kang; Joong-Gu Ji; Chao Zhang; Bao-Jin Hua; Shin-Jyung Kang
Journal:  Chin J Integr Med       Date:  2015-07-04       Impact factor: 1.978

3.  Effect of ginseng polysaccharides on NK cell cytotoxicity in immunosuppressed mice.

Authors:  Yaoyao Sun; Mofei Guo; Yuanjie Feng; Huifang Zheng; Ping Lei; Xiande Ma; Xiaowei Han; Hongquan Guan; Diandong Hou
Journal:  Exp Ther Med       Date:  2016-10-26       Impact factor: 2.447

4.  Antitumor activity of yulangsan polysacchrides in mice bearing S180 sarcoma tumors.

Authors:  Wen'E Cai; Xiaoyu Chen; Qingdong Pan; Shijun Zhang; Luojiao Tan; Xuyong Sun; Renbin Huang; Aijun Xia
Journal:  Mol Clin Oncol       Date:  2017-08-16

5.  Red ginseng polysaccharide exhibits anticancer activity through GPX4 downregulation-induced ferroptosis.

Authors:  Feng-Guo Zhai; Qi-Chao Liang; Yi-Yan Wu; Jia-Qi Liu; Jia-Wei Liu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

6.  Stimulation and suppression of innate immune function by American ginseng polysaccharides: biological relevance and identification of bioactives.

Authors:  Chike G Azike; Paul A Charpentier; Edmund M K Lui
Journal:  Pharm Res       Date:  2014-09-11       Impact factor: 4.200

7.  Synthesis, characterization and cytotoxic activity evaluation of ginsengdiol oxidation and nitrogen hybrid derivatives.

Authors:  Yumeng Zhang; Weihui Yuan; Xude Wang; Hongyu Zhang; Yuanyuan Sun; Xiaoshu Zhang; Yuqing Zhao
Journal:  Medchemcomm       Date:  2018-10-18       Impact factor: 3.597

8.  Anti-cancer and potential chemopreventive actions of ginseng by activating Nrf2 (NFE2L2) anti-oxidative stress/anti-inflammatory pathways.

Authors:  Constance Lay-Lay Saw; Qing Wu; Ah-Ng Tony Kong
Journal:  Chin Med       Date:  2010-10-27       Impact factor: 5.455

9.  An overview of the evidence and mechanisms of herb-drug interactions.

Authors:  Pius S Fasinu; Patrick J Bouic; Bernd Rosenkranz
Journal:  Front Pharmacol       Date:  2012-04-30       Impact factor: 5.810

10.  Extraction of polysaccharides from Fomes officinalis Ames and their antitumor activity.

Authors:  Mingdong Hu; Huifeng Zhang; Bo Feng; Ke Liu; Shuying Guo
Journal:  Exp Ther Med       Date:  2013-06-17       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.